US2021130281A1PendingUtilityA1

Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof

74
Assignee: XWPHARMA LTDPriority: Sep 23, 2015Filed: Jan 14, 2021Published: May 6, 2021
Est. expirySep 23, 2035(~9.2 yrs left)· nominal 20-yr term from priority
C07D 333/38C07D 317/64C07D 309/12C07D 307/68C07D 277/56C07D 213/80C07D 213/79C07D 211/46C07D 207/28C07D 207/16C07C 2601/14C07C 2601/08C07C 317/44C07C 271/34C07C 271/22C07C 233/47C07C 229/36C07C 229/08C07C 69/96C07C 69/92C07C 69/76C07C 69/75C07C 69/74C07C 69/67C07C 69/618C07C 69/612C07C 69/24A61P 25/32A61P 25/30A61P 25/28A61P 25/20A61P 25/18A61P 25/16A61P 25/14A61P 25/00A61P 21/00C07D 277/30C07C 229/34C07C 69/34C07C 255/57C07B 59/001C07D 211/44C07C 69/608C07D 207/12C07C 69/22A61P 29/00C07C 69/78A61K 31/19C07C 2601/06A61P 25/02A61K 31/44C07C 317/14C07C 2601/16C07C 69/28C07C 69/738Y02P20/55
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.

Claims

exact text as granted — not AI-modified
1 - 34 . (canceled) 
     
     
         35 . The compound (S)-4-(2-amino-3-methybutanoyloxy)butanoic acid: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.